Waltham, MA, February 13, 2012 -- BG Medicine, Inc.

Lexington, MA – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled

THE RUSSIA FORUM – Moscow, Russia – February 2, 2012 – Joule today announced the election of Anatoly Chubais to its board of directors, adding the expertise and insight of a prominent figure in international business, economics and government. The news was released in conjunction with Joule’s participation at the Russia Forum, an annual meeting of high-profile international economists and business leaders.

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc. announced today that the Company’s proprietary Lasik Xtra procedure has received Canadian Approval. Lasik Xtra is a two minute procedure used in conjunction with standard Lasik to restore biomechanical integrity and strength to the cornea after a standard Lasik procedure. The procedure combines riboflavin ophthalmic solution with Avedro’s KXL™ System (UVA irradiation) to achieve accelerated corneal cross-linking during a Lasik procedure.

WALTHAM, Mass., Jan 26, 2012 -- Today - at the Online Research Methods conference in London - Affinnova, Inc., the global leader in marketing innovation software and services, introduced Affinnova Concept Studio, a web-based application that accelerates concept collaboration and development for new products, designs and ad campaigns.

Synthetic chemistry company Tetraphase Pharmaceuticals Inc. of Watertown could get $40 million from a federal contract to develop an antibiotic to potentially treat illnesses resulting from biological threats such as anthrax, tularemia or pestis, the company told Mass High Tech in an interview.

Click on Mass High Tech logo to view full article

BOSTON -- Oasys Water, a leader in forward osmosis technology for desalination, brine recovery and water reuse, today announced the appointment of Bob Muscat as Chief Executive Officer. The appointment marks the beginning of the company’s commercialization phase.

CAMBRIDGE, Mass., Jan 23, 2012 (BUSINESS WIRE) -- Selventa(TM), a biomarker discovery company that enables personalized healthcare through stratification of patients based on disease-driving mechanisms, today announced that the U.S. Patent & Trademark Office has issued the Company U.S.

Bedford, Mass. – January 23, 2012 – Joule today announced the appointment of two key executives to manage the company's roll-out of renewable fuel production facilities worldwide. Peter Erich has joined as Executive Vice President, General Manager Commercial Operations, and will lead the team responsible for site development and technology deployment. Paul Snaith has been appointed to build and manage the related partnerships as Head of Business Development & Strategy.

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics, today announced that L. Patrick “Pat” Gage, Ph.D., biopharmaceutical industry pioneer, has been appointed as the company’s Chairman of the Board. In this role, Dr.